Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Lapatinib in Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related Tumors

NCT00973739 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00973739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00973739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Lapatinib in Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related Tumors
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
November 30, 2012
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis 2, vestibular schwannoma